|
Extramural Support
|
RMS2013 [E]
|
$366,054,072
|
$41,217
|
N/A
|
National Cancer Institute
|
|
Molecular Targeted Photoimmunotherapy for Bladder Cancer
|
ZIA BC 011458
|
$201,577
|
$201,577
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Androgen Receptor in Bladder Cancer
|
ZIA BC 011527
|
$37,796
|
$37,796
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillus
|
ZIA BC 011528
|
$5,039
|
$5,039
|
Agarwal, Piyush
|
CCR (NCI)
|
|
High Throughput Screening of Agents in Bladder Cancer Cell Lines
|
ZIC BC 011531
|
$7,559
|
$7,559
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$708,251
|
$70,825
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$273,036
|
$273,036
|
Apolo, Andrea
|
CCR (NCI)
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-27
|
$1,874,946
|
$18,749
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$412,773
|
$412,773
|
Barchi, Joseph
|
CCR (NCI)
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-16
|
$320,126
|
$22,409
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$85,879
|
$21,470
|
Bates, Susan
|
CCR (NCI)
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIA BC 010622
|
$128,818
|
$25,764
|
Bates, Susan
|
CCR (NCI)
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-28S1
|
$362,418
|
$10,873
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA031946-32
|
$9,816,255
|
$687,138
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-29
|
$2,684,982
|
$80,549
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$224,699
|
$67,410
|
Beutler, John
|
CCR (NCI)
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-16
|
$447,372
|
$31,316
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma
|
ZIA BC 011095
|
$132,612
|
$132,612
|
Bottaro, Donald
|
CCR (NCI)
|
|
Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics
|
ZIA BC 011123
|
$79,567
|
$39,784
|
Bottaro, Donald
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$318,269
|
$111,394
|
Bottaro, Donald
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$253,796
|
$177,657
|
Buck, Christopher
|
CCR (NCI)
|
|
Cancer and Leukemia Group B
|
5U10CA032291-32
|
$454,439
|
$31,811
|
Burstein, Harold
|
DANA-FARBER CANCER INST
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$1,048,784
|
$104,878
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Cancer and Leukemia Group B
|
3U10CA077597-14S2
|
$85,066
|
$5,955
|
CHESON, BRUCE
|
GEORGETOWN UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA047577-26
|
$85,701
|
$5,999
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-37
|
$14,566,378
|
$145,664
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,465,171
|
$723,259
|
Custer, Mary
|
CCR (NCI)
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIA BC 011300
|
$536,933
|
$161,080
|
Dean, Michael
|
CCR (NCI)
|
|
Molecular Modeling of the Human P-glycoprotein Transporter Protein
|
ZIC BC 011075
|
$50,263
|
$25,131
|
Durell, Stewart
|
CCR (NCI)
|
|
Molecular Profiling of Clinical Specimens
|
ZIC BC 011040
|
$1,229,426
|
$245,885
|
Edelman, Daniel
|
CCR (NCI)
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$670,870
|
$33,544
|
Feldman, Steven
|
CCR (NCI)
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-24
|
$486,165
|
$4,862
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZIC BC 010548
|
$485,878
|
$48,588
|
Figg, William
|
CCR (NCI)
|
|
Quality Assurance Review Center
|
3U10CA029511-33S1
|
$1,946,959
|
$19,470
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
|
ZIA BC 010625
|
$325,103
|
$162,551
|
Fojo, Antonio
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,497,257
|
$449,726
|
Fojo, Antonio
|
CCR (NCI)
|
|
Radiological Physics Center
|
5U10CA010953-45
|
$2,786,631
|
$27,866
|
Followill, David
|
UT MD ANDERSON CANCER CTR
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$224,566
|
$44,913
|
Fowler, Daniel
|
CCR (NCI)
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$503,081
|
$50,308
|
Garfield, Susan
|
CCR (NCI)
|
|
Biostatistics Data Management Center for ACRIN
|
3U10CA079778-14S1
|
$2,271,308
|
$22,713
|
Gatsonis, Constantine
|
BROWN UNIVERSITY
|
|
Kansas City Clincal Oncology Program CCOP
|
5U10CA035176-29
|
$585,600
|
$5,856
|
Gaur, Rakesh
|
KANSAS CITY CLINICAL ONCOLOGY PROGRAM
|
|
Research Nursing
|
ZID BC 010950
|
$922,235
|
$46,112
|
Giaccone, Giuseppe
|
CCR (NCI)
|
|
Medical Director's Office
|
ZID BC 010951
|
$2,426,933
|
$242,693
|
Giaccone, Giuseppe
|
CCR (NCI)
|
|
Greenville SC CCOP
|
5U10CA067663-18
|
$913,669
|
$9,137
|
Giguere, Jeffrey
|
GREENVILLE HOSPITAL SYSTEM
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$630,367
|
$31,518
|
Gottesman, Michael
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$630,367
|
$31,518
|
Gottesman, Michael
|
CCR (NCI)
|
|
Community Clinical Oncology Program
|
2U10CA035199-30
|
$363,406
|
$3,634
|
GRINBLATT, DAVID
|
NORTHSHORE UNIVERSITY HEALTHSYSTEM
|
|
Molecularly targeted natural products discovery from diverse natural sources
|
ZIA BC 011467
|
$659,534
|
$131,907
|
Gustafson, Kirk
|
CCR (NCI)
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-23S1
|
$125,000
|
$1,250
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-23
|
$431,709
|
$4,317
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
Total relevant funding to Urinary System for this search: $17,558,503
|